Comparison of the specificity and sensitivity of traditional methods for assessment of nephrotoxicity in the rat with metabonomic and proteomic methodologies

Journal of Applied Toxicology

Volumn 25, Issue 4, 2005, Pages 277-295

  Gibbs, Andy ^a  

^a UK   (United Kingdom)

Author keywords

Biomarker; Kidney; Metabonomic; Nephrotoxicity; Proteomic; Renal

Indexed keywords

BIOLOGICAL MARKER; XENOBIOTIC AGENT;

ANALYTIC METHOD; ARTICLE; BLOOD CHEMISTRY; HISTOPATHOLOGY; LABORATORY TEST; LIVER; METABONOMICS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RAT; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; KIDNEY DISEASES; PRINCIPAL COMPONENT ANALYSIS; PROTEOMICS; RATS; TERMINOLOGY; TOXICOLOGY; XENOBIOTICS;

EID: 22844441050     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.1064     Document Type: Article

References (30)

1. Aardema MJ, MacGregor JT. 2002. Toxicology and genetic toxicology in the new era of 'toxicogenomics': impact of Omics' technologies. Mutat. Res. 499: 13-25.
2. Anderson NL, Anderson NG. 1998. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19: 1853-1861.
3. Anthony ML, Gartland KP, Beddell CR, Lindon JC, Nicholson JK. 1994a. Studies of the biochemical toxicology of uranyl nitrate in the rat. Arch. Toxicol. 68: 43-53.
4. Anthony ML, Beddell CR, Lindon JC, Nicholson JK. 1994b. Studies on the comparative toxicity of 5-(1,2-dichlorovinyl)-L-cysteine, S-(1,2-dichlorovinyl)- L-homocysteine and 1,1,2-trichloro-S/S-trifluoro-1-propene in the Fischer 344 rat. Arch. Toxicol. 69: 99-110.
5. Bandara LR, Kennedy S. 2002. Toxicoproteomics - a new preclinical tool. Drug Discov. Today 7: 411-418.
6. Bandara LR, Kelly MD, Lock EA, Kennedy S. 2003a. A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. Toxicol. Sci. 73: 195-206.
7. Bandara LR, Kelly MD, Lock EA, Kennedy S. 2003b. A potential biomarker of kidney damage identified by proteomics: preliminary findings. Biomarkers 8: 272-286.
8. Charlwood J, Skehel JM, King N, Camilleri P, Lord P, Bugelski P, Atif U. 2002. Proteomic analysis of rat kidney cortex following treatment with gentamicine. J. Proteom. Res. 1: 73-82.
9. Cunningham ML, Bogdanffy MS, Zacharewski TR, Hines RN. 2003. Workshop overview: use of genomic data in risk assessment. Toxicol. Sci. 73: 209-215.
10. Cutler P, Bell DJ, Birrell HC, Connelly JC, Connor SC, Holmes E, Mitchell BC, Monte SY, Neville BA, Pickford R, Policy S, Schneider K, Skehel JM. 1999. An integrated proteomic approach to studying glomerular nephrotoxicity. Electrophoresis 20: 3647-3658.
11. FDA. 2005. Guidance for Industry, Pharmacogenomic Data Submissions (Draft Guidance). Washington, DC, Food and Drug Administration [available at: www.fda.gov/cder/guidance/6400fnl.pdf].
12. Griffin JL, Bollard ME. 2004. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. Curr. Drug Metab. 5: 389-398.
13. Hamadeh HK, Amin RP, Paules RS, Afshari CA. 2002. An overview of toxicogenomics. Curr. Issues Mol. Biol. 4: 45-56.
14. Henry CJ, Phillips R, Carpanini F, Corton JC, Craig K, Igarashi K, Leboeuf R, Marchant G, Osborn K, Pennie WD, Smith LL, Teta MJ. 2002. Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. Environ. Health Perspect. 110: 1047-1050.
15. 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11: 235-244.
16. Holmes E, Nicholson JK, Nicholls AW, Lindon JC, Connor SC, Polley S, Connelly J. 1998b. The identification of novel biomarkers of renal toxicity using automated data reduction techniques and PCA of proton NMR spectra of urine. Chemom. Intell. Lab. Syst. 44: 245-255.
17. Holmes E, Nicholson JK, Tranter G. 2001. Metabonomic characterisation of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem. Res. Toxicol. 14: 182-191.
18. Kennedy S. 2001. Proteomic profiling from human samples: the body fluid alternative. Toxicol. Lett. 120: 379-384.
19. Kennedy S. 2002. The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers 7: 269-290.
20. Lindon JC, Nicholson JK, Holmes E, Antti H, Bollard ME, Keun H, Beckonert O, Ebbels TM, Reily MD, Robertson D, Stevens GJ, Luke P, Breau AP, Cantor GH, Bible RH, Niederhauser U, Senn H, Schlotterbeck G, Sidelmann UG. 2003. Contemporary issues in toxicology The role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187: 137-146.
21. MacGregor JT. 2003a. SNPs and chips: genomic data in safety evaluation and risk assessment. Toxicol. Sci. 73: 207-208.
22. MacGregor JT. 2003b. The future of regulatory toxicology: impact of the biotechnology revolution. Toxicol. Sci. 75: 236-248.
23. Mitchell S, Holmes E, Carmichael P. 2002. Metabonomics and medicine: the biochemical oracle. Biologist 49: 217-221.
24. Nicholson JK, Connelly J, Lindon JC, Holmes E. 2002. Metabonomics: a platform for studying drug toxicity and gene function. Nature Rev. Drug Discov. 1: 153-161.
25. Robertson DG, Reily MD, Sigler RE, Wells DF, Paterson DA, Braden TK. 2000. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicol. Sci. 57: 326-337.
26. Wetmore BA, Merrick BA. 2004. Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32: 619-642.
27. Williams RE, Lock EA. 2004. D-Serine-induced nephrotoxicity: possible interaction with tyrosine metabolism. Toxicology 201: 231-238.
28. Williams RE, Lock EA. 2005. Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat. Toxicology 207: 35-48.
29. 1H-Nuclear magnetic resonance pattern recognition studies with N-phenylanthranilic acid in the rat: time- and dose-related metabolic effects. Biomarkers 8: 472-490.
30. Witzmann FA, Fultz CD, Grant RA, Wright LS, Kornguth SE, Siegel FL. 1998. Differential expression of cytosolic proteins in the rat kidney cortex and medulla: preliminary proteomics. Electrophoresis 19: 2491-2497.